title: Telithromycin use and spontaneous reports of hepatotoxicity.
abstract: OBJECTIVE
  Recent reports have described cases of telithromycin-related hepatotoxicity. The objective of this study is to quantify the effect of telithromycin use on the risk of hepatotoxicity.
  
  
  METHODS
  We conducted a spontaneous-report case-control study of hepatotoxicity in telithromycin recipients using reports from the US FDA Adverse Event Reporting System. Reports from between 1 January 2005 and 30 June 2005 were examined. Cases included reports of patients with abnormal liver function tests, hepatocellular damage and hepatic impairment, while patients with reported conditions with similar reporting probabilities were considered as controls. The primary outcome measure of the analysis was the reporting odds ratio (ROR) evaluating the a priori hypothesis that telithromycin use confers an elevated risk of hepatotoxicity relative to other agents.
  
  
  RESULTS
  A total of 2219 cases and 20,667 controls were identified. We estimated an ROR for hepatotoxicity associated with telithromycin compared with other agents of 1.82 (95% CI 1.12, 2.96) after controlling for age and gender, approximating an 82% excess risk in users of telithromycin relative to users of other agents.
  
  
  CONCLUSIONS
  This analysis is the first to specifically quantify the effect of telithromycin on the risk of hepatotoxicity. Telithromycin use may increase the risk of hepatotoxicity by >80%. Biases inherent in spontaneous reports include under-reporting of events and differential or time-varying reporting due to enhanced clinician awareness. Future studies should employ alternative data sources because of the inherent limitations of passive surveillance systems.
authors: Department of Community Health, Brown Medical School, Providence, RI 02903, USA. david_dore@brown.edu
authors: David D
authors: DD
authors: Dore
authors: Julia R
authors: JR
authors: DiBello
authors: Kate L
authors: KL
authors: Lapane
mesh_terms: D000293:Adolescent; D000328:Adult; D016907:Adverse Drug Reaction Reporting Systems; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D016022:Case-Control Studies; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D006801:Humans; D048628:Ketolides / Q000009:adverse effects*; D008107:Liver Diseases / Q000453:epidemiology*; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D014481:United States / Q000453:epidemiology
chemical_list: D000900:Anti-Bacterial Agents; D048628:Ketolides; C106791:telithromycin
references: Otolaryngol Head Neck Surg. 2004 Sep;131(3):207-14
references: 15365537
references: Am J Rhinol. 2003 Nov-Dec;17 (6):369-77
references: 14750614
references: Arch Intern Med. 2004 Jun 14;164(11):1243-6
references: 15197053
references: Am J Public Health. 2005 Mar;95(3):458-65
references: 15727977
references: J Antimicrob Chemother. 1994 Mar;33(3):387-401
references: 8040106
references: JAMA. 2000 Dec 20;284(23):3036-9
references: 11122591
references: J Allergy Clin Immunol. 2005 Feb;115(2):S1-13
references: 15696068
references: N Engl J Med. 2006 Apr 13;354(15):1589-600
references: 16611950
references: South Med J. 2005 Sep;98 (9):863-8
references: 16217977
references: JAMA. 2001 Aug 15;286(7):831-3
references: 11497537
references: Drug Saf. 1999 Feb;20(2):109-17
references: 10082069
references: Ann Intern Med. 2006 Mar 21;144(6):415-20
references: 16481451
references: Drug Alcohol Depend. 2004 Jun 11;74(3):223-34
references: 15194200
references: Addiction. 2003 Sep;98(9):1209-28
references: 12930209
references: Ann Intern Med. 2002 Dec 17;137(12):947-54
references: 12484709
references: J Natl Cancer Inst. 1959 Apr;22(4):719-48
references: 13655060
references: Pharmacoepidemiol Drug Saf. 2004 Aug;13(8):519-23
references: 15317031
references: Infection. 2002 Dec;30(6):378-86
references: 12478329
references: J Antimicrob Chemother. 2004 Aug;54(2):515-23
references: 15269191
references: Ear Nose Throat J. 2003 Aug;82(8):576-80, 82-4, 586 passim
references: 14503094
references: Chest. 2005 Oct;128(4):1980-8
references: 16236845
references: Clin Ther. 2004 Jan;26(1):48-62
references: 14996517
references: Pharmacoepidemiol Drug Saf. 2005 Dec;14(12):869-75
references: 15818636
references: Clin Ther. 1998;20 Suppl C:C40-4
references: 9915089
references: Clin Gastroenterol Hepatol. 2005 Dec;3(12):1260-8
references: 16361053